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Day-Level Associations Between Substance Use
and HIV Risk Behavior Among a Diverse Sample
of Transgender Women
Brett M. Millar,1 Devin English,1 Raymond L. Moody,1,2 H. Jonathon Rendina,1–3,* Demetria Cain,1,4
Nadav Antebi-Gruszka,1,5 Joseph A. Carter,1,2 and Jeffrey T. Parsons1–3
Abstract
Purpose: Transgender women in the United States face elevated rates of HIV and of substance use. Studies mea-
suring overall or aggregate levels of substance use have linked use to increased HIV transmission risk behavior
(TRB). Although intensive longitudinal studies in other populations have found day-level links between substance
use and TRB, no study has yet explored such links among transgender women. This study aimed to fill this gap in
the literature.
Methods: Utilizing survey and 60-day timeline follow-back interview data from a sample of 214 transgender
women in New York City, we tested whether day-level heavy drinking, marijuana use, and/or nonprescription
stimulant use were associated with odds of engaging in any sex (vs. no sexual activity) or engaging in TRB
(vs. sex without TRB), adjusting for overall levels of use.
Results: Multilevel models showed that each of the three substance types was associated with greater odds of
engaging in sex on a given day—and more strongly so for heavy drinking among those with higher rates of
heavy drinking, and for stimulant use among those with lower rates of stimulant use. Only marijuana use was
associated with greater odds of TRB on a given day, but only among those with higher rates of use.
Conclusion: These findings substantiate day-level links between substance use and engaging in sexual activity
among transgender women, and importantly, between marijuana use and greater likelihood of TRB on a day
when sexual activity occurs. This highlights the importance of addressing substance use for sexual health
among transgender women especially focusing on marijuana use.
Keywords: alcohol; drug use; harm reduction; intensive longitudinal data; prevention
Introduction
In efforts to better understand and address health inequi-
ties experienced by transgender women—defined as indi-
viduals assigned a male sex at birth who currently identify
their gender as female—greater knowledge is needed re-
garding risk factors for adverse health outcomes.1 One
prominent health inequity facing transgender women
in the United States is elevated rates of HIV, with an es-
timated prevalence rate of 21.6%,2,3 likely rooted in dis-
crimination and oppression, and involving high rates of
poverty, unemployment, and lack of social support.4–9
Accordingly, the need for a greater understanding of
risk factors influencing HIV transmission risk behavior
(TRB) among transgender women is paramount.
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Numerous cross-sectional studies have observed as-
sociations between overall or summed substance use
indicators (e.g., averaged use over a given period, or
any use vs. none) and rates of TRB among transgender
women.10–16 This link between substance use and TRB
is especially concerning given the findings of other
studies showing that transgender women also have
comparatively high rates of substance use.17–21
These cross-sectional findings resonate with exten-
sive work that has focused on substance use as a risk
factor in TRB among other populations such as het-
erosexual cisgender women and men22,23 and gay and
bisexual men.24,25 However, research in these other
populations has built upon these cross-sectional find-
ings by studying associations between substance use
on a given day and subsequent TRB events occurring
on the same day.26–28 For example, Rendina et al.27 ob-
served day-level links between heavy drinking, mari-
juana, and club drug use and sexual behavior among
gay and bisexual men, whereby use of each substance
(especially club drugs) was associated with (1) in-
creased odds of engaging in any sexual activity (though
not necessarily TRB), and (2) increased odds of engage-
ment in TRB (vs. sex that did not involve TRB) on that
day. By including the individual’s overall or aggregated
level of use, analyses were able to show that the day-
level associations for club drug use and for marijuana
were stronger among less frequent users compared
with those who use more frequently. This kind of nu-
anced information highlights the value of intensive lon-
gitudinal analyses and is not possible in cross-sectional
studies analyzing overall use. Unfortunately, day-level
studies focusing on transgender women are scarce.
To our knowledge, the only event-level study on sub-
stance use and TRB among transgender women is the
study by Delgado et al. 29 in Peru that combined gay
and bisexual men with transgender women and only
asked about alcohol use and the most recent sex event
with up to three partners in the past 90 days.
Accordingly, we aimed to address this gap in the lit-
erature by examining whether substance use on a given
day was associated with engagement in any sex and/or
with engagement in sex involving TRB, among a di-
verse sample of transgender women in New York
City. Specifically, we aimed to test day-level associa-
tions between heavy drinking (defined as having five
or more drinks in the one sitting), marijuana, or non-
prescription stimulant drugs on sexual engagement
and sexual TRB. These variables are given in Table 1.
Given the comparatively high rates of substance use
generally observed among transgender women, we
aimed to adjust for the individual’s average level of
use for each of the three substance types and to test
whether the individual’s average level of use moder-
ated the day-level associations for each outcome. We
hypothesized that, on days of substance use, the posi-
tive associations between use and both sexual engage-
ment and sexual TRB would be even greater among
transgender women with comparatively lower overall
rates of use, and that the associations would still re-
main significant, although less strong, among trans-




Participants were 214 transgender women from the
New York City metropolitan area who completed base-
line visits for a substance use and sexual risk behavioral
intervention tailored to transgender women, Project
T-Talk, between May 2014 and September 2016. For
recruitment, we adapted a mix of active, passive, and
online strategies that we have previously used to recruit
gay and bisexual men.30–32 Active strategies included
collaborating with community-based organizations,
visiting venues, bars, and nightclubs, and building in-
terpersonal connections and trust within local trans-
gender communities through meetings and events.
Additional passive recruitment efforts included distrib-
uting study recruitment materials to health clinics spe-
cializing in medical, mental health, and substance use
treatment for transgender women. Online recruitment
efforts consisted of emailing LISTSERVS, sending Proj-
ect Newsletter emails to transgender women who had
expressed interest in participating and advertising on
social networking websites (e.g., Facebook, Craigslist).
We also provided drop-in hours to maximize flexibility
for participants to attend the initial baseline visit through-
out the day and evenings.
Table 1. Summary of Study Predictors and Outcomes
Day-level predictor variables
Day-level outcomesHeavy drinking on a given day
The odds of engaging
in any sex (vs. no sex)
Using marijuana on a given day
The odds of engaging in
sexual TRB (vs. sex that
does not involve TRB)
Using stimulant drugs on a given day
Individual-level predictor variables
Overall frequency of heavy drinking
Overall frequency of marijuana use
Overall frequency of stimulant drug use
TRB, transmission risk behavior.
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We screened a total of 487 transgender women, 382
(78%) of whom met the criteria for study eligibility.
These criteria included being 18 years old or older,
being able to complete a survey in English, being a
transgender woman (i.e., assigned a male sex at birth
and identifying as female at the time of participation),
providing contact information, living in New York City
metropolitan area, and reporting at least one sexual act
or one day of drug use in the past 60 days. We deemed
participants ineligible if they were currently enrolled
in a substance abuse treatment or an HIV risk or sub-
stance use intervention. Of the 219 transgender women
who attended the baseline assessment, 214 completed
all measures of interest and were included in the ana-
lytic sample for this study. The baseline assessment
lasted between 70 and 150 min and consisted of a sur-
vey that assessed demographic characteristics and psy-
chosocial factors (e.g., depressive symptoms), and a
timeline follow-back (TLFB) interview (Sobell and
Sobell, 1992) that assessed sexual behavior and sub-
stance use in the past 60 days (Irwin et al., 2006). Par-
ticipants received $40 for their participation in the
baseline assessment. The Hunter College Institutional
Review Board approved all study protocols.
Measures
Demographics. Participants self-reported their race
and ethnicity, gender identity (i.e., whether participants
consider themselves to be a transgender woman or a
woman of transgender experience), relationship status
(i.e., whether they are currently seeing someone they
consider to be a main partner), sexual orientation iden-
tity (coded as heterosexual vs. lesbian, gay, bisexual, or
queer; LGBQ), HIV status (with an HIV-negative
status confirmed by testing or an HIV-positive status
confirmed with documentation), annual income (in
brackets of $10,000), level of education, current age,
and the age when the participant first began living as a
woman.
Behavioral variables. Participants completed a 60-day
TLFB interview,33,34 indicating substance use and sex
that occurred over the 60 days before the baseline as-
sessment. For the present analyses, we focused on
daily reports of heavy drinking (i.e., having five or
more alcoholic drinks), use of marijuana, and use of
nonprescription stimulants (i.e., cocaine/crack, ecstasy,
methamphetamine), in line with the analytic plan of
Rendina et al.27 For each day, we created three di-
chotomous indicators of whether the participant had
engaged in heavy drinking, marijuana use, or nonpre-
scription stimulants, and used these variables as day-
level (i.e., Level 1) indicators of substance use within
our models. We also aggregated these three daily sub-
stance use indicators to the individual level to serve
as global count variables indicating the number of days
of use for each substance (i.e., Level 2).
For days on which a participant reported sex, we
coded whether it was penetrative sex (i.e., involving
vaginal or anal intercourse), whether condoms were
used, whether it was with a casual partner or with a
main partner who was of known discordant or un-
known HIV status, and whether the event involved
transactional sex (i.e., any exchange of sex for housing
or money). We coded any act in which a participant
had condomless penetrative sex with any casual part-
ner and/or with a main partner of discordant or
unknown HIV status as TRB. We did not collect in-
formation from all participants on whether they were
using preexposure prophylaxis (PrEP) and also did
not measure whether their partners were using PrEP,
and were thus unable to include PrEP usage in our def-
inition of TRB—however, PrEP use was very rare in the
early stages of data collection and it is unlikely to have a
substantial impact on results. To match the day-level
substance use variables, we aggregated event-level sex-
ual behavior data to the day level. Specifically, we cre-
ated two variables to use as outcomes within our
models: (1) a dichotomous indicator of whether any
sexual activity occurred that day and (2) a trichoto-
mous indicator of whether the participant engaged in
no sex (coded as 0), sexual activity without TRB (e.g.,
mutual masturbation, oral sex, penetrative sex with a
condom, condomless penetrative sex with a known sero-
concordant partner; coded as 1), or sex involving TRB
(coded as 2).
Data analysis plan
We began by examining descriptive statistics to charac-
terize the demographic makeup of the sample. Next, we
examined Spearman nonparametric correlations be-
tween the aggregated substance use count variables
(i.e., days of heavy drinking, days of marijuana use,
and days of nonprescription stimulant use) and the ag-
gregate number of days having sex and sex involving
TRB. We then ran a series of multilevel models, with
day-level dichotomous indicators of heavy drinking,
marijuana use, and nonprescription stimulant use at
Level 1 and individual-level aggregated frequencies of
use for each substance as a count variable at Level 2.
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For the first outcome, whether or not participants en-
gaged in any sexual activity on a given day, we used a
binary logistic outcome (Model 1). For the second out-
come, the trichotomous variable indicating whether the
participant had no sex, had sex without TRB, or sex
with TRB on a given day, we used a multinomial logis-
tic model (Model 2). Although we used all data (both
sex days and nonsex days) to calculate coefficients for
Model 2, we focused our analysis on the portion of
the model comparing sex days without TRB and TRB
days. As such, we do not report comparisons with non-
sex days in Model 2.
We ran both models with cross-level interactions
between corresponding day-level and grand mean
centered individual-level substance use (e.g., day-level
heavy drinking by individual-level heavy drinking)
to examine whether associations between day-level
substance use and marginal probabilities for sexual
engagement and TRB on a given day varied based
on an individual’s overall level of substance use. As
such, these models included the following independent
variables: day-level use of each of the three substance
types (Level 1), aggregate individual-level use for each
substance type (Level 2), and an interaction between
corresponding substance categories on each level. We
ran models with a random intercept, using an AR(1) co-
variance structure, and adjusted for HIV-positive status,
relationship status, and day within the TLFB frame
(i.e., 1 through 60 days). We also ran additional ana-
lyses adjusting for whether the sex event involved
transactional sex to check if patterns remained consistent.
Results
Demographic characteristics are given in Table 2.
Approximately a third of the sample identified as
Black/African American, 28% identified as Latina, a
quarter identified as white, 13% identified as multira-
cial, and the remaining five participants identified as
Asian. A majority of participants had an HIV-negative
status (65.4%), had a yearly income below $20,000
(80.4%), and had an education level of some college
or more (57.9%). Approximately half of the partici-
pants reported being partnered (49.1%) and LGBQ
identified (52.8%). Marijuana was the most frequently
used substance with a mean use of 20.5 days and a me-
dian use of 7.0 days. Heavy drinking days (M = 5.4,
SD = 9.2, median = 1) and nonprescription stimulant
use days (M = 4.5, SD = 10.1, median = 0) were rela-
tively less frequent during the 60-day period for most
participants. The mean number of sex days was 12.6
(SD = 13.9) during the 60-day period, with 85.5% of
participants reporting at least two or more sex days.
The mean number of TRB days was 4.3 (SD = 10.1),
with 40.2% of participants reporting at least two or
more TRB days.
Aggregate-only analyses
Table 3 provides bivariate correlations between ag-
gregated sex days, TRB days, substance use days, and
two covariates: HIV status and relationship status.
We found that the number of sex days was positively
correlated with total heavy drinking days, total stimulant
use days, and being partnered—but not with marijuana
use days. The number of TRB days was correlated only
with total number of sex days. Aggregate levels of use
among the three substances were positively correlated
with each other such that, if a participant used one sub-
stance more frequently, they were more likely also to do
Table 2. Demographic Characteristics and Prevalence
of Outcomes Among Transgender Women in New York
City (N = 214)
n %
Race/ethnicity


















Below $20K 172 80.4
$20K or more 42 19.6
Education
High school or less 90 42.1
Some college 62 29.0
Bachelor degree 49 22.9
Graduate degree 13 6.1
M SD
Age (years; range 18–65) 34.3 11.7
Age of first living as a woman (n = 208) 22.4 10.0
Number of heavy drinking days (median = 1.0) 5.4 9.2
Number of marijuana use days (median = 7.0) 20.5 24.2
Number of stimulant use days (median = 0.0) 4.5 10.1
Number of days of any sexual activity (median = 8.0) 12.6 13.9
Number of sexual TRB days (median = 1.0) 4.3 10.1
LGBQ, lesbian, gay, bisexual, queer.
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so for the other substances. Overall, marijuana use and
stimulant use were more frequently common among
HIV-positive participants. Relationship status was not
associated with use of any of the three substances.
Simultaneous models of aggregate-level
and day-level substance use
Table 4 provides the two multilevel models predict-
ing odds of sexual engagement versus no engagement
(Model 1) and odds of sex with TRB versus sex without
TRB (Model 2). In Model 1, day-level heavy drinking
(adjusted odds ratio [AOR] = 2.30, p < 0.001), mari-
juana use (AOR = 3.53, p < 0.001), and stimulant use
(AOR = 9.10, p < 0.001) were all associated with signifi-
cantly greater odds of sexual engagement (vs. no sex)
on a given day. However, in Model 2, only day-level
marijuana use (AOR = 2.69, p < 0.001) was significantly
associated with greater odds of engaging in TRB (vs.
sex without TRB). Although day-level heavy drinking
trended in the positive direction, suggesting greater
odds of TRB, it did not reach statistical significance.
Regarding individual-level effects, aggregate number
of stimulant use days (AOR = 1.05, p < 0.01) was associ-
ated with greater odds of engaging in sex on a given day
Table 3. Bivariate Spearman Correlations Between Totals (of the Previous 60 Days) of Sex Days, Sexual TRB Days,
Substance Use Days, and Covariates
1 2 3 4 5 6 7
1. No. of sex days 1
2. No. of sexual TRB days 0.37*** 1
3. No. of heavy drinking days 0.28*** 0.11 1
4. No. of marijuana days 0.10 0.02 0.16* 1
5. No. of stimulant drug days 0.30*** 0.08 0.31*** 0.18** 1
6. HIV Status (Ref = HIV-negative) 0.07 0.09 0.12 0.19** 0.17* 1




Table 4. Multilevel Models Utilizing Day-Level and Individual-Level Substance Use to Predict Sexual Engagement
and Sexual Transmission Risk Behavior
Model 1a Model 2b
No Sex vs. Sex Non-TRB vs. TRB
b AOR 95% CI b AOR 95% CI
Intercept 2.63 0.07*** 0.05–0.11 1.85 0.16*** 0.07–0.34
Day 0.01 0.99*** 0.99–1.00 0.00 1.00 0.99–1.00
HIV-status (Ref = HIV negative) 0.17 1.18 0.71–1.97 0.32 1.37 0.60–3.12
In relationship (Ref = Single) 0.68 1.97** 1.23–3.16 0.84 0.43* 0.20–0.93
Level 1: day-level effects
Day-level heavy drinking 0.83 2.30*** 1.75–3.02 0.32 1.38 0.84–2.27
Day-level marijuana use 1.26 3.53*** 2.88–4.32 0.99 2.69*** 1.64–4.41
Day-level stimulant use 2.21 9.10*** 6.39–12.97 0.19 0.83 0.46–1.51
Level 2: individual-level effects
Frequency of heavy drinking 0.02 0.98 0.95–1.01 0.00 1.00 0.95–1.05
Frequency of marijuana use 0.01 0.99 0.97–1.00 0.04 0.96* 0.93–0.99
Frequency of stimulant use 0.05 1.05** 1.02–1.08 0.04 1.04 0.99–1.08
Day · individual effects
Day-level · frequency of heavy drinking 0.07 1.07*** 1.05–1.10 0.01 0.99 0.95–1.04
Day-level · frequency of marijuana use 0.01 0.99 0.98–1.00 0.04 1.04* 1.00–1.08





bMultinomial logistic regression (only one of two comparisons are given). All models were adjusted for HIV status and relationship status and also
day of data collection (i.e., day of timeline follow-back cycle).
AOR, adjusted odds ratio.
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(Model 1), indicating that those with more days of
stimulant use in the 60-day period generally reported
more days of engaging in sexual activity. In addition,
aggregate marijuana use (AOR = 0.96, p < 0.05) was as-
sociated with lower odds of engaging in TRB on a given
day (Model 2). This indicates that those with more days
of marijuana use in the 60-day period generally reported
fewer events of TRB when sexual activity did occur.
We next examined the interaction effects be-
tween day-level substance use and individual-level sub-
stance use. In Model 1, we found that individual-level
heavy drinking moderated the association between
day-level heavy drinking and odds of engaging in sex
(AOR = 1.07, p < 0.001)—the positive association be-
tween day-level drinking and sexual engagement was
higher among individuals who engaged in heavy drink-
ing more often (Fig. 1). In the opposite direction, we
found that individual-level stimulant use significantly
moderated the association between day-level stimu-
lant use and odds of engaging in sex (AOR = 0.95,
p < 0.001), such that lower overall stimulant users had
a greater increase in odds of sexual engagement on a
day of use than those with more frequent use overall
(Fig. 1).
In Model 2, we found that individual-level mari-
juana use moderated the positive association between
day-level marijuana use and odds of engaging in TRB
(AOR = 1.04, p < 0.05). Although those with more fre-
quent overall marijuana use tended to have lower odds
of engaging in TRB on a sex day, the positive day-level
association between marijuana use and their odds of
TRB was stronger than for those with lower overall mar-
ijuana use (Fig. 2). Among those with lower overall mar-
ijuana use, the odds of engaging in TRB were not higher
FIG. 1. Marginal probabilities of engaging in sexual activity based on individual and day-level use of
substances. Note: Low substance use and high substance use are defined at the 25th and 75th percentiles,
respectively.
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on a day of marijuana use versus a day of no marijuana
use. The patterns were not meaningfully altered in addi-
tional analyses when we adjusted for whether the event
involved transactional sex.
Discussion
This study is, to our knowledge, the first to test for day-
level associations between substance use (here, heavy
drinking, marijuana use, and/or nonprescription stim-
ulant use) and sexual behavior focusing on transgender
women. We found that, as hypothesized, use of any of
these three substance types on a given day was associ-
ated with greater odds of engaging in sexual activity on
that day (compared with not engaging in sexual activ-
ity) among a diverse sample of New York City-based
transgender women. Indeed, heavy drinking was asso-
ciated with more than twice the odds of sexual engage-
ment on a given day, marijuana use was associated with
>3.5 times the odds of sexual engagement, and stimu-
lant use was associated with >9 times the odds of sexual
engagement on that day. These findings that substance
use and sexual activity often co-occur for transgender
women are consistent with research on samples of cis-
gender women23 and gay and bisexual men,25,27 sug-
gesting that substance use on a given day was a more
informative predictor of sexual engagement compared
with overall levels of use.
Our hypotheses regarding day-level associations be-
tween substance use and greater odds of sexual TRB,
however, were only partially supported. Only mari-
juana use on a given day was associated with greater
odds of engaging in TRB compared with sex without
TRB, at >2.5 times the odds. Although heavy drinking
was in the hypothesized direction of increasing the
odds of TRB, its local main effect did not reach statis-
tical significance. The marijuana finding is consistent
with evidence that marijuana use should be considered
among the disinhibiting substances regarding sexual
health,35 and suggests that interventions targeting
the role of marijuana use on behaviors such as TRB
among transgender women should be prioritized.
However, the lack of significant findings for day-level
heavy drinking and stimulant use predicting TRB
in this study stands in contrast to previous studies—
mostly examining overall frequencies of substance
use—which have observed significant positive associ-
ations among transgender women10,15,16 and among
other populations.26–28
Finally, we also tested whether these associations
differed according to the individual’s overall level of
use. We found that the day-level association between
heavy drinking and sexual engagement was stronger
in those who engaged in heavy drinking more fre-
quently, whereas the association between stimulant
use and sexual engagement was stronger in those
who engaged in less frequent use of stimulants overall.
In terms of TRB, the day-level association between
marijuana use and odds of TRB was stronger among
those with greater overall marijuana use, counter to
our hypothesis. These results suggest that the impact
FIG. 2. Marginal probabilities of engaging in sexual TRB based on individual-level and day-level use of
substances. Note: Low substance use and high substance use are defined at the 25th and 75th percentiles,
respectively. TRB, transmission risk behavior.
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of marijuana on TRB on a given day is influenced by
how frequently the substance is used by the individual
in general.
This study begins to address a substantial gap in
the literature on the influence of substance use on sex-
ual behavior at the event-level among transgender
women—and the findings have important implications
in terms of HIV prevention efforts, particularly regard-
ing marijuana use. Existing research on overall or ag-
gregate substance use has found that transgender
women who engage in more frequent use are at greater
risk of engaging in TRB—suggesting that HIV preven-
tion efforts should focus on transgender women who
engage in more frequent substance use.11–15 Although
our study cannot confirm the mechanism/s involved
in the link between marijuana and TRB, our findings
highlight the need to provide individuals frequently
using marijuana with information and strategies to ad-
dress links between their use and sexual risk behavior.
In terms of intervention implications, behavioral and
motivational enhancement interventions have been
shown to be effective at reducing substance use and
sexual risk behavior among transgender women36
and gay and bisexual men.37,38 Some of these interven-
tions incorporate a harm-reduction philosophy aimed
at minimizing risk associated with substance use and
sexual engagement. This study has implications for
harm-reduction approaches to treatment for trans-
gender women who may be resistant or ambivalent
about totally eliminating their substance use. Among
these, strategies may include reducing the quantity
of use on a day of use, increasing self-efficacy for
use of condoms or engaging in less risky sexual behav-
ior, or increasing uptake of and adherence to medica-
tions (e.g., antiretroviral therapy; PrEP). The benefits
of harm reduction on substance use and sexual health
have been noted in other studies, such as a recent
trial of a harm-reduction intervention that focused
on gay and bisexual men that saw significant reduc-
tions in stimulant use, sexual partners, and receptive
anal intercourse.39
The findings from this study should be considered in
light of some limitations. First, the results of this study
are based on a convenience sample who reported at
least one recent sexual act or one recent drug use
day, and thus these findings may not generalize to all
transgender women. Second, this study utilized a
TLFB interview to assess substance use and sexual be-
havior retrospectively. TLFB interviews are considered
to be more accurate than other forms of retrospective
recall but the risk of recall bias is still present.40
Although previous research has demonstrated relative
consistency between retrospective and prospective as-
sessments of substance use and sexual behavior,27 fu-
ture research should examine these associations using
prospective assessment methods (e.g., ecological mo-
mentary assessment). Third, day-level drinking did
involve consideration of quantity of use, but our mea-
sures of day-level marijuana use and stimulant drug
use did not ask participants about the quantity of their
use on a given day. Fourth, our analyses were not able
to adjust for PrEP use by the participants’ partners or
for the detectability of either person’s viral load in
each sexual event. Furthermore, our definition of sex-
ual TRB mainly pertains to risk for HIV transmission
and did not address the possibilities for sexually trans-
mitted infections occurring through other types of
sexual activity (classified in this study as non-TRB sex-
ual engagement). Future research may seek to explore
the role of substance use on these other sexual health
outcomes.
Conclusions
In sum, this study provides valuable, nuanced informa-
tion about day-level links between substance use and
sexual behavior among a sample of New York City-
based transgender women. In part, our findings high-
light the need to distinguish between different types
of substances when addressing substance use in rela-
tion to sexual risk behavior among transgender
women, given the differing patterns observed. In addi-
tion, the tailoring of harm-reduction and contingency-
planning interventions according to the individual’s
overall level of use for each substance type is also rec-
ommended. Finally, it should be noted that a potential
interpretation of our finding that both heavy drinking
and stimulant use were positively associated with en-
gaging in some sexual activity but not with engaging
in TRB sex could be that, despite heavy drinking or
stimulant use on a given day, many of the transgen-
der women in our sample were able to navigate sex-
ual activity with a partner without engaging in TRB.
Further explorations of mechanisms and strategies
used in these situations to prevent or avoid TRB
may yield important insights for the sexual health
of this population.
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